Video Buzz v1

Related Hemoglobinuria News

Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute - MSN MoneyCentral

Alexion Licenses PDL's Queen et al. Patents for Soliris(R) INCLINE VILLAGE, Nev. , and CHESHIRE, Conn. , Jan. 5 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (Nasdaq: PDLI) and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today jointly announced that ...

Alexion Settles Legal Dispute - Xconomy

Alexion Pharmaceuticals (NASDAQ: ALXN ) reports it will pay $25 million to PDL BioPharma (NASDAQ: PDLI ) to license a patent related to humanizing antibodies and to settle a legal dispute between the two companies. Cheshire, CT-based Alexion says the ...

PDL BioPharma, Alexion settle patent dispute - Boston Globe

NEW YORK? PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. said Monday they settled a patent dispute over the blood disorder drug Soliris, in a cash for rights exchange. Soliris is Cheshire, Conn.-based Alexion's only marketed product. Approved ...

UPDATE 1-Alexion, PDL BioPharma settle patent dispute - Reuters

Jan 5 (Reuters) - Alexion Pharmaceuticals Inc ( ALXN.O ) confirmed that its genetic disorder drug Solaris used technology covered by one of PDL BioPharma Inc ( PDLI.O ) patents and entered into a $25-million licensing deal with PDL. Under the ...

Alexion settles lawsuit over patent for anemia treatment - Providence Journal

Alexion Pharmaceuticals Inc., which has a drug manufacturing plant in Smithfield, has agreed to pay $25 million to PDL BioPharma Inc. to license patents used for Alexion?s Soliris anemia treatment, settling a lawsuit over claims that the company ...

Hemoglobinuria Podcasts

Do you prefer to listen to your hemoglobinuria gossip? Check out Podzy Podcast Directory > Hemoglobinuria.

Hemoglobinuria Products

Looking for hemoglobinuria related products, then look no further. Try our new Hemoglobinuria Shop.